Real-time polymerase chain reaction in multiple myeloma
- 1 June 2002
- journal article
- research article
- Published by Elsevier in Experimental Hematology
- Vol. 30 (6) , 529-536
- https://doi.org/10.1016/s0301-472x(02)00794-4
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Real-time polymerase chain reaction of immunoglobulin rearrangements for quantitative evaluation of minimal residual disease in multiple myelomaTransplantation and Cellular Therapy, 2000
- Quantitative detection of t(14;18)-positive cells in patients with follicular lymphoma before and after autologous bone marrow transplantationBone Marrow Transplantation, 2000
- Multiple myeloma: the number of reinfused plasma cells does not influence outcome of patients treated with intensified chemotherapy and PBPC supportBone Marrow Transplantation, 2000
- Antitumor Activity of Thalidomide in Refractory Multiple MyelomaNew England Journal of Medicine, 1999
- CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATIONBritish Journal of Haematology, 1998
- Multiple myeloma: reduced plasma cell contamination in peripheral blood progenitor cell collections performed after repeated high-dose chemotherapy coursesBritish Journal of Haematology, 1997
- Plasma cells in peripheral blood stem cell harvests from patients with multiple myeloma are predominantly polyclonalBone Marrow Transplantation, 1997
- Monoclonal plasma cells in the blood stem cell harvest from patients with multiple myeloma are associated with shortened relapse-free survival after transplantationBone Marrow Transplantation, 1997
- A plasmocyte selective monoclonal antibody (B‐B4) recognizes syndecan‐1British Journal of Haematology, 1996
- Detection of minimal residual disease by polymerase chain reaction in b cell malignanciesThe International Journal of Cell Cloning, 1995